LivaNova PLC (NASDAQ:LIVN) had its price objective raised by Needham & Company LLC from $83.00 to $89.00 in a report published on Friday morning, Marketbeat reports. Needham & Company LLC currently has a buy rating on the stock.
Several other equities research analysts also recently issued reports on the company. ValuEngine raised LivaNova PLC from a hold rating to a buy rating in a report on Thursday. Canaccord Genuity reiterated a hold rating and set a $71.00 price objective on shares of LivaNova PLC in a research report on Wednesday, September 20th. Jefferies Group LLC increased their price objective on LivaNova PLC from $76.00 to $80.00 and gave the stock a buy rating in a research report on Friday, September 15th. Piper Jaffray Companies reiterated an overweight rating and set a $75.00 price objective on shares of LivaNova PLC in a research report on Tuesday, September 12th. Finally, WBB Securities cut LivaNova PLC from a hold rating to a sell rating and set a $50.00 price objective on the stock. in a research report on Tuesday, August 15th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company’s stock. LivaNova PLC presently has a consensus rating of Hold and an average price target of $76.00.
Shares of LivaNova PLC (NASDAQ:LIVN) traded down $1.05 during trading on Friday, reaching $80.72. The company’s stock had a trading volume of 290,815 shares, compared to its average volume of 426,465. The firm has a market cap of $3,941.78, a price-to-earnings ratio of 23.56, a P/E/G ratio of 2.46 and a beta of 0.52. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.42 and a current ratio of 2.03.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.17. LivaNova PLC had a return on equity of 9.33% and a net margin of 4.63%. The business had revenue of $309.70 million during the quarter, compared to the consensus estimate of $301.22 million. During the same quarter last year, the firm posted $0.78 EPS. The company’s quarterly revenue was up 4.9% on a year-over-year basis. analysts expect that LivaNova PLC will post 3.33 earnings per share for the current fiscal year.
In other LivaNova PLC news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $68.55, for a total transaction of $68,550.00. Following the transaction, the director now owns 57,296 shares in the company, valued at approximately $3,927,640.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold a total of 3,000 shares of company stock worth $203,890 in the last quarter. Company insiders own 0.28% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the business. Franklin Resources Inc. increased its position in shares of LivaNova PLC by 7.5% in the second quarter. Franklin Resources Inc. now owns 5,089,070 shares of the company’s stock worth $311,515,000 after purchasing an additional 354,956 shares during the period. BlackRock Inc. increased its position in shares of LivaNova PLC by 79.3% in the second quarter. BlackRock Inc. now owns 4,648,780 shares of the company’s stock worth $284,552,000 after purchasing an additional 2,055,891 shares during the period. State Street Corp increased its position in shares of LivaNova PLC by 74.8% in the second quarter. State Street Corp now owns 1,835,428 shares of the company’s stock worth $112,345,000 after purchasing an additional 785,268 shares during the period. Koch Industries Inc. bought a new position in shares of LivaNova PLC in the second quarter worth $1,384,000. Finally, Dimensional Fund Advisors LP increased its position in shares of LivaNova PLC by 55.0% in the second quarter. Dimensional Fund Advisors LP now owns 922,229 shares of the company’s stock worth $56,450,000 after purchasing an additional 327,395 shares during the period. Hedge funds and other institutional investors own 81.69% of the company’s stock.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
What are top analysts saying about LivaNova PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LivaNova PLC and related companies.